Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy

By Morales E.   Andres A.   Gonzalez E.   Herrero J.C.   Munoz M.A.   Ortiz M.   Espejo B.   Lumbreras C.   Morales J.M.   Aguado J.M.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 73-74

Elsevier

Access to resources Recommend Favorite

Development of anti-HLA-antibodies against intra-CREG-mismatches in renal transplant recipients

By Papassavas A.C.   Iniotaki-Theodoraki A.   Boletis J.   Kostakis A.   Stavropoulos-Giokas C.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 757-759

Elsevier

Access to resources Recommend Favorite

Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients

By Ravindranath Mepur H.   Pham Tho   Ozawa Miyuki   Terasaki Paul I.  

International Immunology, Vol. 24, Iss. 1, 2012-01 ,pp. : 43-57

Oxford University Press

Access to resources Recommend Favorite

Anti-class II antibodies in kidney transplant patients

By Rebibou J.M.   Bittencourt M.C.   Ducloux D.   Chabod J.   Thevenin C.   Chalopin J.M.   Herve P.   Tiberghien P.  

Transplantation Proceedings, Vol. 32, Iss. 8, 2000-12 ,pp. : 2748-2749

Elsevier

Access to resources Recommend Favorite

Pretransplant serum IgA concentration and IgA-anti-fab autoantibody activity in living donor renal transplant recipients: a pilot study

By Kim M.S.   Kim Y.S.   Kim S.I.   Lee J.W.   Moon J.I.   Park K.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 2977-2978

Elsevier

Access to resources Recommend Favorite